Insulet stock (NASDAQ: PODD) currently trades around $200 per share, about 35% lower than the levels of over $300 seen in early November 2021. In comparison, its peer – DexCom stock – is down 55% over ...

PODD is Intuitive Surgical’s counterpart in the Health Care Equipment sector that has: 1) A lower valuation (P/OpInc) in comparison to Intuitive Surgical stock 2) However, it exhibits higher revenue ...

Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Following a robust ...

Insulet Corporation (NASDAQ:PODD) is among the 10 High Growth S&P 500 Stocks to Buy Now. Truist on February 19, 2026, lowered ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Fintel reports that on May 7, 2024, Wolfe Research upgraded their outlook for Insulet (NasdaqGS:PODD) from Peer Perform to Outperform. As of May 2, 2024, the average one-year price target for Insulet ...

Shares of Insulet Corp. PODD shed 1.47% to $241.84 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.94% to 6,816.63 and Dow ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Shares of Insulet Corp. PODD slipped 1.63% to $237.01 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...